Clinical Trial Update: QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial comparing trabectedin plus pegylated liposomal doxorubicin versus platinum-based therapy in platinum-sensitive recurrent ovarian cancer; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Platinum-sensitive Recurrent Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Doxil (liposomal doxorubicin)
• Yondelis (trabectedin)

Snippet

Sponsor: North Eastern German Society of Gynaecological Oncology | Conditions: Quality of Life, Ovarian Cancer | Phase 4 | Status: TERMINATED | Results posted: 2025-03-20